 |
|
|
| |
Pharmacokinetic and virological efficacy of dolutegravir (50 mg BID) containing regimen in association with rifampin in HIV-infected patients using Dried Blood Spot: ANRS-12313
NAMSAL sub-study in Cameroon
|
| |
| |
Reported by Jules Levin
19th International Workshop on Clinical Pharmacology of Antiviral Therapy 2018, 22-24 May 2018 Baltimore, USA
Le M1,2, Cournil A3, Eymard-Duvernay S3, Kouanfack C4, Lem S5, Le Gac S5, Delaporte E3, Peytavin G1,2
1AP-HP, Hôpital Bichat, Paris, France, 2IAME, UMR 1137, INSERM, Université Paris Diderot, Sorbonne Paris Cité, Paris, France, 3TransVIHMI, IRD, INSERM, Université de Montpellier, Montpellier,
France, 4Central Hospital, Yaoundé, Cameroon, 5ANRS, Yaoundé, Cameroon
|
| |
|
|
|
|
|
